SC
AZN icon

Sapient Capital’s AstraZeneca AZN Stock Holding History

Sapient Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.38M Sell
8,433
-159
-2% -$26.5K 0.02% 173
2026
Q2 		$1.61M Buy
8,592
+4,962
+137% +$933K 0.02% 166
2026
Q1 		$703K Buy
3,630
+1,730
+91% +$334K 0.01% 232
2025
Q4 		$352K Buy
+1,900
New +$333K ﹤0.01% 316

Other funds holding AZN

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
PAS
Professional Advisory Services Vero Beach, Florida $837M AUM 20.44% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return
PNC
Park National Corp Newark, Ohio $3.69B AUM 18.32% 1-Year Est. Return
CCM
Cox Capital Management Andover, Massachusetts $179M AUM 28.94% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CNBT
Canandaigua National Bank & Trust Canandaigua, New York $1.15B AUM
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
PC
Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return
TF
TLWM Financial San Antonio, Texas $628M AUM 12.21% 1-Year Est. Return

Sapient Capital's AZN Position: Q3 2026 in Review

Sapient Capital reduced its AstraZeneca (AZN) stake by 1.9% in Q3 2026, selling an estimated $26.5K and leaving 8,433 shares worth $1.38M. The position accounts for 0.02% of the portfolio, ranked #173.

Sapient Capital first reported a position in AZN in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.61M in Q2 2026. 51 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Sapient Capital held 8,433 shares of AstraZeneca worth $1.38M as of Q3 2026.
  • Sapient Capital sold 159 AstraZeneca shares in Q3 2026, an estimated $26.5K.
  • AstraZeneca made up 0.02% of Sapient Capital's portfolio in Q3 2026, its #173 holding.
  • Sapient Capital first reported a position in AstraZeneca in Q4 2025 and has held it in 4 quarters since.
  • Sapient Capital's AstraZeneca position peaked at $1.61M in Q2 2026.
  • 51 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Sapient Capital's 13F filing for Q3 2026, filed 8 Oct 2026.